Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Analysis of Medication Errors Reported by Community Pharmacists in the Republic of Korea: A Cross-Sectional Study
Conclusions: The MEs reported by community pharmacists were mainly prescribing errors, most of which were rectified before reaching patients. The prevalent medications involved in harmful errors include anti-diabetic, anti-thrombotic, and anti-inflammatory agents.PMID:36676775 | PMC:PMC9866739 | DOI:10.3390/medicina59010151 (Source: Medicina (Kaunas))
Source: Medicina (Kaunas) - January 21, 2023 Category: Universities & Medical Training Authors: Ju-Hee Han Kyu-Nam Heo JiMin Han Mo-Se Lee Su-Jin Kim Sangil Min Young-Mi Ah Ju-Yeun Lee Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
Clinical Evidence and Practice-Based Guidelines on the Utility of Basal insulin combined Oral therapy (metformin and glimepiride) in the current era
CONCLUSION: These current clinical practice guidelines highlight the efficacy and safety of basal insulin combination therapy with various available basal insulins including neutral protamine hagedorn, detemir, glargine and degludec in addition to metformin and glimepiride therapy.PMID:36624650 | DOI:10.2174/1573399819666230109104300 (Source: Current Diabetes Reviews)
Source: Current Diabetes Reviews - January 10, 2023 Category: Endocrinology Authors: Abhishek Shrivastava Jothydev Kesavadev Viswanathan Mohan Banshi Saboo Dina Shrestha Anuj Maheshwari Brij Mohan Makkar Kirtikumar D Modi Ashok Kumar Das Source Type: research
In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin
Ann Intern Med. 2023 Jan 3. doi: 10.7326/J22-0105. Online ahead of print.ABSTRACTGRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997.PMID:36592466 | DOI:10.7326/J22-0105 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - January 2, 2023 Category: Internal Medicine Authors: Krysta Brown Anthony A Donato Source Type: research
In type 2 diabetes, glargine and liraglutide each improved glycemic outcomes at 5 y vs. glimepiride or sitagliptin
Ann Intern Med. 2023 Jan 3. doi: 10.7326/J22-0104. Online ahead of print.ABSTRACTGRADE Study Research Group; Nathan DM, Lachin JM, Balasubramanyam A, et al. Glycemia reduction in type 2 diabetes-glycemic outcomes. N Engl J Med. 2022;387:1063-74. 36129996.PMID:36592465 | DOI:10.7326/J22-0104 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - January 2, 2023 Category: Internal Medicine Authors: Krysta Brown Anthony A Donato Source Type: research
In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin
Ann Intern Med. 2023 Jan 3. doi: 10.7326/J22-0105. Online ahead of print.ABSTRACTGRADE Study Research Group; Nathan DM, Lachin JM, Buse JB, et al. Glycemia reduction in type 2 diabetes-microvascular and cardiovascular outcomes. N Engl J Med. 2022;387:1075-88. 36129997.PMID:36592466 | DOI:10.7326/J22-0105 (Source: Annals of Internal Medicine)
Source: Annals of Internal Medicine - January 2, 2023 Category: Internal Medicine Authors: Krysta Brown Anthony A Donato Source Type: research
